Agios Pharmaceuticals, Inc. AGIO
$37.00
-0.51%
at last close
Recent SEC Filings
| Form | Description | Filed | Document |
|---|---|---|---|
| 4 | FORM 4 | 2026-10-23 | View → |
| 4 | FORM 4 | 2026-08-06 | View → |
| 10-Q | 10-Q | 2026-07-30 | View → |
| 8-K | 8-K | 2026-07-30 | View → |
| 4 | FORM 4 | 2026-07-10 | View → |
| 4 | FORM 4 | 2026-07-02 | View → |
| 4 | FORM 4 | 2026-06-23 | View → |
| 4 | FORM 4 | 2026-06-23 | View → |
| 4 | FORM 4 | 2026-06-23 | View → |
| 4 | FORM 4 | 2026-06-23 | View → |
| 4 | FORM 4 | 2026-06-23 | View → |
| 4 | FORM 4 | 2026-06-23 | View → |
| 4 | FORM 4 | 2026-06-23 | View → |
| 4 | FORM 4 | 2026-06-23 | View → |
| 4 | FORM 4 | 2026-06-23 | View → |
| 4 | FORM 4 | 2026-06-23 | View → |
| 4 | FORM 4 | 2026-06-23 | View → |
| 4 | FORM 4 | 2026-06-23 | View → |
| 4 | FORM 4 | 2026-06-23 | View → |
| 4 | FORM 4 | 2026-06-23 | View → |
| 4 | FORM 4 | 2026-06-23 | View → |
| 8-K | 8-K | 2026-06-18 | View → |
| 4 | FORM 4 | 2026-06-16 | View → |
| 4 | FORM 4 | 2026-06-16 | View → |
| 10-Q | 10-Q | 2026-04-29 | View → |
| 8-K | 8-K | 2026-04-29 | View → |
| DEF 14A | DEF 14A | 2026-04-24 | View → |
| 4 | FORM 4 | 2026-04-06 | View → |
| 4 | FORM 4 | 2026-04-06 | View → |
| 4 | FORM 4 | 2026-04-06 | View → |
| 4 | FORM 4 | 2026-04-06 | View → |
| 4 | FORM 4 | 2026-04-06 | View → |
| 4 | FORM 4 | 2026-04-06 | View → |
| 4 | FORM 4 | 2026-03-09 | View → |
| 4 | FORM 4 | 2026-03-05 | View → |
| 4 | FORM 4 | 2026-03-03 | View → |
| 4 | FORM 4 | 2026-03-03 | View → |
| 4 | FORM 4 | 2026-03-03 | View → |
| 4 | FORM 4 | 2026-03-03 | View → |
| 4 | FORM 4 | 2026-03-03 | View → |
Filings are sourced directly from the SEC's EDGAR system. Annual reports (10-K) and quarterly reports (10-Q) carry the full financial statements; 8-K filings disclose material events between reports; Form 4 filings record insider purchases and sales.
Key Stats
- Last Close
- $37.00
- Market Cap
- $2.21 billion
- 52-Week Range
- $22.24 – $46.00
- Average Volume
- 1.17 million shs
Data is delayed and provided for informational purposes only. Not investment advice. See our disclaimer.